Ingevity Corp (NGVT) stock forecast and price target
Price $61.72 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($61.72)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $5.39 | +18.5% | $1.1B |
| Next fiscal year ends December 31, 2027 | $5.96 | +10.6% | $1.1B |
| Next quarter ends December 31, 2026 | $0.87 | +38.6% | $232M |
| Quarter after ends March 31, 2027 | $1.21 | +4.8% | $252M |
Consensus of the analysts covering Ingevity, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Our model vs. Wall Street
Analysts see 43.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Ingevity’s intrinsic value about 62% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Ingevity stock price target?
The average 12-month target from 3 analysts is $88.67, 43.7% above the current price of $61.72 Targets range from $85.00 to $95.00.
Is Ingevity a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 2 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Ingevity expected to earn?
Analysts expect EPS of $5.39 for the fiscal year ending December 31, 2026 and $5.96 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.